Related Experiment Video
Updated: Aug 20, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci
Philip Domenico1, Ellen Gurzenda, Andrea Giacometti
1Cardio Pulmonary Research Institute, Winthrop-University Hospital, SUNY Stony Brook School of Medicine, Mineola 11501, New York, NY, USA. pdomenico@winthrop.org
Abstract:
Staphylococci are a major cause of infections associated with indwelling medical devices. Biofilm formation on these devices adds to the antibiotic resistance seen among clinical isolates. RNAIII-inhibiting peptide (RIP) is a heptapeptide that inhibits staphylococcal pathogenesis, including biofilm formation, by obstructing quorum sensing mechanisms. Bismuth ethanedithiol (BisEDT) also prevents biofilm formation at subinhibitory concentrations. RIP and BisEDT were combined to prevent infections in a rat graft model, using antibiotic sensitive and resistant strains of Staphylococcus aureus and Staphylococcus epidermidis. BisEDT, RIP, or rifampin, or their combinations reduced the graft associated bacterial load over seven days. BisEDT-RIP was the best combination, reducing bacterial load to undetectable levels. BisEDT-RIP may prove useful for coating medical devices to prevent staphylococcal infections.
Insights
Combining RNAIII-inhibiting peptide (RIP) and Bismuth ethanedithiol (BisEDT) effectively prevented staphylococcal infections and biofilm formation on medical devices in a rat model, reducing bacterial load to undetectable levels.
Area of Science:
- Microbiology
- Infectious Diseases
- Biomaterials Science
Background:
- Staphylococcal infections are common with indwelling medical devices.
- Biofilm formation by Staphylococci contributes to antibiotic resistance.
- Quorum sensing mechanisms are key to staphylococcal pathogenesis and biofilm development.
Purpose of the Study:
- To evaluate the efficacy of RNAIII-inhibiting peptide (RIP) and Bismuth ethanedithiol (BisEDT), alone and in combination, in preventing staphylococcal infections and biofilm formation.
- To assess the effectiveness against both antibiotic-sensitive and resistant strains of Staphylococcus aureus and Staphylococcus epidermidis.
Main Methods:
- A rat graft model was used to simulate medical device-associated infections.
- Treatment groups included BisEDT, RIP, rifampin, and their combinations.
- Bacterial load on grafts was quantified over a seven-day period.
Main Results:
- All tested agents (BisEDT, RIP, rifampin) and their combinations reduced graft-associated bacterial load.
- The combination of BisEDT and RIP demonstrated the most significant reduction in bacterial levels.
- The BisEDT-RIP combination reduced bacterial load to undetectable levels.
Conclusions:
- The combination of BisEDT and RIP is highly effective in preventing staphylococcal infections and biofilm formation.
- BisEDT-RIP holds promise for coating medical devices to mitigate device-associated staphylococcal infections.
- This combination therapy offers a potential strategy against antibiotic-resistant staphylococcal strains.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Staphylococcal Skin Infections